What is Flora Growth?
Flora Growth Corp. is a vertically integrated company focused on the cultivation, development, and distribution of medicinal cannabis and derivative products globally. Operating across distinct segments including House of Brands, Commercial and Wholesale, and Pharmaceuticals, the company is involved in every stage of the value chain. Flora Growth produces medicinal-grade cannabis flower and a diverse range of wellness products, including those under its JustCBD, Vessel, and Phatebo brands. Its pharmaceutical division is dedicated to developing treatments for various health indications, such as cancer therapies, ADHD, multiple sclerosis, and depression, leveraging both medical cannabis and pharmaceutical goods.
How much funding has Flora Growth raised?
Flora Growth has raised a total of $50.3M across 3 funding rounds:
Stock Offering
$16.7M
Stock Offering
$30M
Private Equity
$3.6M
Stock Issuance/Offering (2021): $16.7M, investors not publicly disclosed
Stock Issuance/Offering (2021): $30M, investors not publicly disclosed
Private Equity (2025): $3.6M, investors not publicly disclosed
What's next for Flora Growth?
The substantial enterprise-level capital infusion, highlighted by the recent strategic investment, positions Flora Growth for accelerated scaling and market penetration. This backing is likely to support the expansion of its cultivation facilities, enhance its research and development capabilities in pharmaceuticals, and broaden the distribution of its branded wellness and medicinal cannabis products. The company's focus on a diversified product portfolio, from consumer wellness items to pharmaceutical treatments, suggests a strategy aimed at capturing multiple market segments within the global cannabis industry. Future developments may include strategic partnerships, further product line extensions, and potential international market expansions.
See full Flora Growth company page
